Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk Factors, and Outcomes
Overview
Authors
Affiliations
Coronavirus disease 2019 (COVID-19) has become a pandemic, but its reported characteristics and outcomes vary greatly amongst studies. We determined pooled estimates for clinical characteristics and outcomes in COVID-19 patients including subgroups by disease severity (based on World Health Organization Interim Guidance Report or Infectious Disease Society of America/American Thoracic Society criteria) and by country/region. We searched Pubmed, Embase, Scopus, Cochrane, Chinese Medical Journal, and preprint databases from 1 January 2020 to 6 April 2020. Studies of laboratory-confirmed COVID-19 patients with relevant data were included. Two reviewers independently performed study selection and data extraction. From 6007 articles, 212 studies from 11 countries/regions involving 281 461 individuals were analyzed. Overall, mean age was 46.7 years, 51.8% were male, 22.9% had severe disease, and mortality was 5.6%. Underlying immunosuppression, diabetes, and malignancy were most strongly associated with severe COVID-19 (coefficient = 53.9, 23.4, 23.4, respectively, all P < .0007), while older age, male gender, diabetes, and hypertension were also associated with higher mortality (coefficient = 0.05 per year, 5.1, 8.2, 6.99, respectively; P = .006-.0002). Gastrointestinal (nausea, vomiting, abdominal pain) and respiratory symptoms (shortness of breath, chest pain) were associated with severe COVID-19, while pneumonia and end-organ failure were associated with mortality. COVID-19 is associated with a severe disease course in about 23% and mortality in about 6% of infected persons. Individuals with comorbidities and clinical features associated with severity should be monitored closely, and preventive efforts should especially target those with diabetes, malignancy, and immunosuppression.
COVID-19 clinical presentation, management, and epidemiology: a concise compendium.
Maison D, Tasissa H, Deitchman A, Peluso M, Deng Y, Miller F Front Public Health. 2025; 13:1498445.
PMID: 39957982 PMC: 11826932. DOI: 10.3389/fpubh.2025.1498445.
Maleki B, Sadeghian A, Ranjbar M BMC Infect Dis. 2025; 25(1):144.
PMID: 39885405 PMC: 11783754. DOI: 10.1186/s12879-025-10530-4.
Nirmalarajah K, Aftanas P, Barati S, Chien E, Crowl G, Faheem A BMC Infect Dis. 2025; 25(1):132.
PMID: 39875869 PMC: 11773898. DOI: 10.1186/s12879-025-10450-3.
Mesalles-Ruiz M, Alonso M, Cruellas M, Plana M, Penella A, Portillo A J Clin Med. 2025; 14(2).
PMID: 39860640 PMC: 11765842. DOI: 10.3390/jcm14020633.
ACCREDIT: Validation of clinical score for progression of COVID-19 while hospitalized.
Melo V, do Brasil P Glob Epidemiol. 2025; 9():100181.
PMID: 39850445 PMC: 11754157. DOI: 10.1016/j.gloepi.2024.100181.